Literature DB >> 16124946

Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS.

P Massaroti1, N M Cassiano, L F Duarte, D R Campos, M A M Marchioretto, G Bernasconi, S Calafatti, F A P Barros, E C Meurer, J Pedrazzoli.   

Abstract

PURPOSE: A sensitive, robust, and selective liquid chromatographic-tandem mass spectrometric method (LC-MS/MS) was developed and validated for paroxetine quantification in human EDTA plasma.
METHODS: Sample preparation was based on liquid-liquid extraction using a mixture of ethyl acetate/hexane (50/50; v/v) to extract the drug and internal standard from plasma. Chromatography was performed on a C-18 analytical column and the retention times were 1.6 and 1.7 for paroxetine and fluoxetine (IS), respectively. The ionization was optimized using ESI(+) and selectivity was achieved by tandem mass spectrometric analysis using MRM functions, 330.0 --> 70.0 and 310 --> 43.9 for paroxetine and fluoxetine.
RESULTS: Analytical curve ranged from 0.2 to 20.0 ng/mL. Inter-day precision and accuracy of the quality control (QC) samples were < 15% relative standard deviation (RSD). Analyte stability during sampling processing and storage were established.
CONCLUSION: Validation results on linearity, specificity, accuracy, precision as well as application to the analysis of samples taken up to 120 h after oral administration of 20 mg of paroxetine in 28 healthy volunteers were found to be of good performance in bioequivalence study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16124946

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  7 in total

1.  Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).

Authors:  M Walsh; F Belal; Nahed El-Enany; H Elmansi
Journal:  J Fluoresc       Date:  2010-07-01       Impact factor: 2.217

2.  Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period.

Authors:  Matteo Moretti; Francesca Freni; Beatrice Valentini; Claudia Vignali; Angelo Groppi; Silvia Damiana Visonà; Antonio Marco Maria Osculati; Luca Morini
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

3.  Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone.

Authors:  Simeon Rüdesheim; Dominik Selzer; Thomas Mürdter; Svitlana Igel; Reinhold Kerb; Matthias Schwab; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

4.  New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  Anal Chem Insights       Date:  2008-11-18

5.  Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-naphthoquinone-4-sulphonate as a chromogenic reagent.

Authors:  Ibrahim A Darwish; Heba H Abdine; Sawsan M Amer; Lama I Al-Rayes
Journal:  Int J Anal Chem       Date:  2009-04-22       Impact factor: 1.885

6.  Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene.

Authors:  M I Walash; F Belal; N El-Enany; H El-Mansi
Journal:  Int J Biomed Sci       Date:  2010-09

7.  High-throughput liquid chromatography tandem mass spectrometry method for simultaneous determination of fampridine, paroxetine, and quinidine in rat plasma: Application to in vivo perfusion study.

Authors:  Suneetha Achanti; Raja Rajeswari Katta
Journal:  J Food Drug Anal       Date:  2016-04-13       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.